echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Science Immunology: Why are men more prone to cancer and often have worse outcomes?

    Science Immunology: Why are men more prone to cancer and often have worse outcomes?

    • Last Update: 2022-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Patients with non-reproductive cancers, such as bladder and liver cancers, differ significantly in incidence, progression, response to treatment, and survival outcomes, depending on the sex of the patient


    CD8+ T cells have great potential to eliminate malignant cells, and they kill tumor cells by recognizing different antigens, however, under continuous antigen stimulation, CD8+ T cells often lose their function in the tumor microenvironment, i.


    T cell exhaustion in the tumor microenvironment may be affected by a variety of factors, such as regulatory T cells, inhibitory cytokines, immune checkpoint receptors and ligands, metabolism, etc.


    On April 14, 2022, Li Zihai of Ohio State University and Li Xue of Harvard Medical School published a research paper titled: Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer in the journal Science Immunology .


    Science Immunology Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer

    The study investigated differences in tumor immune responses between men and women in cancers of non-reproductive origin, finding and revealing that androgens promote CD8+ T cell depletion, which leads to faster tumor cell growth


    This landmark discovery highlights the promoting role of androgen-mediated CD8+ T cell dysfunction in cancer, suggests a role for sex differences in health and disease, and provides a new direction for cancer immunotherapy


    Highlights the promoting role of androgen-mediated CD8+ T cell dysfunction in cancer, suggests sex differences in health and disease, and provides new directions for cancer immunotherapy

    Overall, these findings highlight the promoting role of androgen-mediated CD8+ T cell dysfunction in cancer, with important implications for addressing gender disparities in cancer treatment, said the study's corresponding author, Professor Li Zihai from The Ohio State University.


    Li Zihai (left), Li Xue (right)

    Li Zihai (left), Li Xue (right)

    Androgen is the most abundant sex hormone in males


    Androgen is a sex hormone that is higher in males.


    Note: The Sry gene is a sex-determining gene located on the Y chromosome.


    Next, the research team further revealed the mechanism behind it.


    The research team also demonstrated that the use of androgen receptor inhibitors or androgen deprivation therapy (ADT) can significantly enhance the efficacy of PD-1 immune checkpoint inhibitors


    Collectively, this study is the first to demonstrate for the first time that androgen signaling directly regulates Tcf7 and induces CD8+ T cell depletion, and that blocking the androgen receptor in CD8+ T cells alone allows male mice to perform as well as female mice Fights cancer and enhances the efficacy of PD-1 inhibitors


    Original source:

    Original source:

    HYUNWOO KWON, JOHANNA M.


    HYUNWOO KWON, JOHANNA M.
    SCHAFER, et al.
    Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer .
    SCIENCE IMMUNOLOGY, 14 Apr 2022.
    Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.